Harpreet Singh

Active 1974–2026

425
Papers
25,019
Citations
86
h-index
307
i10-index

Citations

Citations per year for Harpreet Singh1950: 1 citations1975: 1 citations1978: 1 citations1979: 4 citations1980: 2 citations1982: 6 citations1983: 4 citations1984: 1 citations1986: 3 citations1987: 2 citations1988: 2 citations1989: 3 citations1991: 6 citations1992: 1 citations1993: 3 citations1994: 2 citations1995: 2 citations1996: 5 citations1997: 4 citations1998: 5 citations1999: 5 citations2000: 9 citations2001: 6 citations2002: 9 citations2003: 20 citations2004: 35 citations2005: 64 citations2006: 81 citations2007: 105 citations2008: 129 citations2009: 110 citations2010: 148 citations2011: 94 citations2012: 105 citations2013: 116 citations2014: 135 citations2015: 101 citations2016: 130 citations2017: 135 citations2018: 146 citations2019: 385 citations2020: 662 citations2021: 821 citations2022: 923 citations2023: 880 citations2024: 1,426 citations2025: 778 citations2026: 50 citations1951–1974: no citations, so these years are not shown1976–1977: no citations, so these years are not shown1981: no citations, so this year is not shown1985: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,265 citing papers, 19.1% of this breakdownChina: 1,410 citing papers, 11.9% of this breakdownIndia: 805 citing papers, 6.8% of this breakdownUnited Kingdom: 632 citing papers, 5.3% of this breakdownItaly: 580 citing papers, 4.9% of this breakdownGermany: 503 citing papers, 4.2% of this breakdownCanada: 370 citing papers, 3.1% of this breakdownAustralia: 346 citing papers, 2.9% of this breakdownFrance: 335 citing papers, 2.8% of this breakdownSpain: 270 citing papers, 2.3% of this breakdownJapan: 225 citing papers, 1.9% of this breakdownSouth Korea: 211 citing papers, 1.8% of this breakdown
0%19.1%Other 33%

Fields

  • Medicine37.8%
  • Biochemistry, Genetics and Molecular Biology21.7%
  • Computer Science11.1%
  • Neuroscience8.8%
  • Engineering5%
  • Materials Science2.5%
  • Other13.1%

Topics

  • Cancer Immunotherapy and Biomarkers2.1%
  • Neural dynamics and brain function1.6%
  • vaccines and immunoinformatics approaches1.6%
  • Lung Cancer Treatments and Mutations1.4%
  • EEG and Brain-Computer Interfaces1.3%
  • Functional Brain Connectivity Studies1.3%
  • Other90.7%

Coauthors

All papers

Open in search
  1. Exploring Computer Science Students’ Perception of ChatGPT in Higher Education: A Descriptive and Correlation Study

    Authors: , , - Education Sciences 2023 cited by 136

  2. Breakdown of Cortical Effective Connectivity During Sleep

    Authors: , , , , , - Science 2005 cited by 1,609

  3. FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 305

  4. Analyzing driver behavior under naturalistic driving conditions: A review

    Authors: , - Accident Analysis & Prevention 2020 cited by 290

  5. UVC radiation for food safety: An emerging technology for the microbial disinfection of food products

    Authors: , , , , - Chemical Engineering Journal 2020 cited by 231

  6. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nancy Diao, Daniel Díaz, Wendel Mombaque dos Santos, David W. Eyre, Coralith Garcia, Georgina Haines–Woodhouse, Mohammed Bheser Hassen, Nathaniel J Henry, Susan Hopkins, Md Mahbub Hossain, Kenneth Iregbu, Chidozie C D Iwu, Jan Jacobs, Mark Janko, Ronald N. Jones, Ibraheem M. Karaye, Ibrahim A. Khalil, Imteyaz Ahmad Khan, Taimoor Khan, Jagdish Khubchandani, Suwimon Khusuwan, Adnan Kısa, Giscard Wilfried Koyaweda, Fiorella Krapp, Emmanuelle A. P. Kumaran, Hmwe Hmwe Kyu, Stephen S Lim, Xuefeng Liu, Stephen P. Luby, Sandeep Maharaj, Christopher Maronga, Miquel Martorell, Jürgen May, Barney McManigal, Ali H. Mokdad, Catrin E. Moore, Ebrahim Mostafavi, Efrén Murillo‐Zamora, Marisa Márcia Mussi‐Pinhata, Ruchi Nanavati, Hasan Nassereldine, Zuhair S. Natto, Farah Naz Qamar, Virginia Núñez-Samudio, Theresa J. Ochoa, Tolulope R Ojo-Akosile, Andrew T Olagunju, Antonio Olivas‐Martínez, Edgar Ortíz‐Brizuela, Pradthana Ounchanum, José Luis Paredes, Venkata Suresh Patthipati, Shrikant Pawar, Marcos Pereira, Andrew J. Pollard, Alfredo Ponce‐de‐León, Elton Junio Sady Prates, Ibrahim Qattea, Luis Felipe Reyes, Emmanuel Roilides, Víctor Rosenthal, Kristina E. Rudd, Weerawut Sangchan, Samroeng Seekaew, Allen Seylani, Niloufar Shababi, Sunder Sham, José Sifuentes‐Osornio, Harpreet Singh, Andy Stergachis and 12 more - The Lancet Regional Health - Americas 2023 cited by 111

  7. Nanomaterial-based fluorescent biosensors for the detection of antibiotics in foodstuffs: A review

    Authors: , , , , , , - Food Chemistry 2023 cited by 134

  8. FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 164

  9. Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 346

  10. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 297

  11. FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 164

  12. Skeletal muscle action of estrogen receptor α is critical for the maintenance of mitochondrial function and metabolic homeostasis in females

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sylvia C. Hewitt, Kenneth S. Korach, Andrea L. Hevener - Science Translational Medicine 2016 cited by 260

  13. Smart education literature: A theoretical analysis

    Authors: , - Education and Information Technologies, Educ. Inf. Technol. 2020 cited by 149

  14. FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation–Positive Low-Grade Glioma

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 71

  15. FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 167

  16. FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , - The Oncologist 2021 cited by 145

  17. FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 82

  18. Regulatory implications of ctDNA in immuno-oncology for solid tumors

    Authors: , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2023 cited by 64

  19. FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 107

  20. FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 56

  21. A New Hybrid Algorithm Based on Grey Wolf Optimization and Crow Search Algorithm for Unconstrained Function Optimization and Feature Selection

    Authors: , , , , - IEEE Access 2019 cited by 238

  22. Cloud Computing-Based Framework for Breast Cancer Diagnosis Using Extreme Learning Machine

    Authors: , , , , , , , - Diagnostics 2021 cited by 183

  23. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6

    Authors: , , , , , , , - Stem Cell Research & Therapy 2018 cited by 182

  24. Advances in MXenes-based optical biosensors: A review

    Authors: , , , , - Biosensors and Bioelectronics 2022 cited by 103